Patent details

EP3765072 Title: 3",5"-DIALKOXYBENZOYL-3'-AMINO-3'-DEOXYADENOSINE-5'-TRIPHOSPHATES AND PHARMACEUTICAL USES THEREOF

Basic Information

Publication number:
EP3765072
PCT Application Number:
US2019022213
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP197679632
PCT Publication Number:
WO2019178331
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
3",5"-DIALKOXYBENZOYL-3'-AMINO-3'-DEOXYADENOSINE-5'-TRIPHOSPHATES AND PHARMACEUTICAL USES THEREOF
French Title of Invention:
3",5"-DIALCOXYBENZOYL-3'-AMINO-3'-DÉSOXYADÉNOSINE-5'-TRIPHOSPHATES ET LEURS UTILISATIONS PHARMACEUTIQUES
German Title of Invention:
3",5"-DIALKOXYBENZOYL-3'-AMINO-3'-DEOXYADENOSIN-5'-TRIPHOSPHATE UND IHRE PHARMAZEUTISCHE VERWENDUNGEN
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
23/08/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
03/09/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
31/07/2024
Unitary Effect Registration Date:
03/09/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
14/03/2019
Grant date:
31/07/2024
EP Publication Date:
20/01/2021
PCT Publication Date:
19/09/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/07/2024
EP B1 Publication Date:
31/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/03/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/07/2024
 
 

Name:
Danmir Therapeutics, LLC
Address:
24 Dartmouth Lane, Haverford, PA 19041, United States (US)

Inventor

1

Name:
MAHADEVAN, Anu
Address:
United States (US)

2

Name:
MORENCY, Cynthia
Address:
United States (US)

3

Name:
LI, Jie
Address:
United States (US)

4

Name:
PELLEG, Amir
Address:
United States (US)

Priority

Priority Number:
201862643199 P
Priority Date:
15/03/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; C12N 15/67; A61P 29/00; A61P 31/12; C07H 19/20;

Publication

European Patent Bulletin

1

Issue number:
202431
Publication date:
31/07/2024
Description:
Grant (B1)

2

Issue number:
202440
Publication date:
02/10/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202440
Publication date:
02/10/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages